Categories
How to Cite
Abstract
Dear Editor,
Our study aims to compare the short-term adverse effects and their consequences between the RNAm vaccines Commirnaty® (Pfizer) and Spikevax® (Moderna), as well as these short-term adverse effects and their consequences between the first and second doses of these vaccines with each other. Possible long-term adverse effects were not the subject of our study…
References
Inglés Torruella J, Gil Soto R, Sabaté E, Garcia Grau M, Pons Boronat N, Rubio Civit A, Bandera Baez M, Moreno Martín G. Estudio de reactogenicidad en las vacunas mRNA frente a la COVID-19. Arch Prev Riesgos Labor. 2023;26(2):106-126.
Parés-Badell O, Martínez-Gómez X, Pinós L, Borras-Bermejo B, Uriona S, Otero-Romero S, et al. Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection. Vaccines. 2021;9:1463.
Tré-Hardy M, Cupaiolo R, Papleux E, Wilmet A, Horeanga A, Antoine-Moussiaux T, et al. Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers. J Infect. 2021;83(2):237-279.
Krammer, F, Srivastava, K and Simon, V. Robust spike antibody responses and increased reactogenicity in seropositive individuals after a 1 single dose of SARS-CoV-2 mRNA vaccine. MedRxiv. 2021.
Raw RK, Kelly CA, Rees J, Wroe C, Chadwick DR. Previous COVID-19 infection, but not Long-COVID, is associated with increased adverse events following BNT162b2/Pfizer vaccination. J Infect. 2021;83(3):381-412.
Mathioudakis AG, Ghrew M, Ustianowski A, Ahmad S, Borrow R, Papavasi-leiou LP, et al. Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient Survey. Life (Basel). 2021;11(3):249.
Centro de Coordinación de Alertas y Emergencias Sanitarias. Actualización nº 630. Enfermedad por el coronavirus (COVID-19). 02.09.2022. [Cited Speptember 02, 2022]. Available at: https://www.sanidad.gob.es/profesionales/saludPublica/cca-yes/alertasActual/nCov/documentos/Actualizacion_630_COVID-19.pdf
Centers for Disease Control and Prevention. The Moderna COVID-19 Vaccine’s Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events. [Cited October 07, 2022.] Available at: https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html
Centers for Disease Control and Prevention. Pfizer-BioNTech COVID-19 Vaccine Reactions & Adverse Events. [Cited October 07, 2022.] Available at: https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Joan Ingles Torruella, Rosa Maria Gil Soto, Esther Sabaté Aguila, Mercé García Grau, Nina Pons Boronat, Adelaida Rubio Civit, Miriam Bandera Baez, Gustavo Moreno Martín